Related Experiment Video
Updated: Nov 10, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano1, Marta J C Jordāo1, Johanna A Joyce2,3
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Abstract:
Strategies to therapeutically target the tumor microenvironment (TME) have emerged as a promising approach for cancer treatment in recent years due to the critical roles of the TME in regulating tumor progression and modulating response to standard-of-care therapies. Here, we summarize the current knowledge regarding the most advanced TME-directed therapies, which have either been clinically approved or are currently being evaluated in trials, including immunotherapies, antiangiogenic drugs, and treatments directed against cancer-associated fibroblasts and the extracellular matrix. We also discuss some of the challenges associated with TME therapies, and future perspectives in this evolving field. SIGNIFICANCE: This review provides a comprehensive analysis of the current therapies targeting the TME, combining a discussion of the underlying basic biology with clinical evaluation of different therapeutic approaches, and highlighting the challenges and future perspectives.
Insights
Targeting the tumor microenvironment (TME) offers a promising cancer treatment strategy. This review covers advanced TME therapies, including immunotherapies and antiangiogenic drugs, alongside challenges and future directions.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The tumor microenvironment (TME) critically influences tumor progression and treatment response.
- Targeting the TME is a rapidly advancing area in cancer therapy.
- Understanding TME components is key to developing effective treatments.
Purpose of the Study:
- To review current knowledge on advanced therapies targeting the tumor microenvironment.
- To discuss clinically approved and investigational TME-directed treatments.
- To explore challenges and future perspectives in TME-targeted cancer therapy.
Main Methods:
- Comprehensive literature review of TME-directed therapies.
- Analysis of immunotherapies, antiangiogenic drugs, and treatments targeting cancer-associated fibroblasts and extracellular matrix.
- Evaluation of clinical trial data and basic science principles.
Main Results:
- Several TME-directed therapies, including immunotherapies and antiangiogenic agents, are in clinical use or trials.
- Treatments targeting cancer-associated fibroblasts and the extracellular matrix show therapeutic potential.
- Significant progress has been made in understanding TME biology and its therapeutic implications.
Conclusions:
- Targeting the tumor microenvironment represents a significant frontier in cancer treatment.
- Further research is needed to overcome challenges and optimize TME-directed therapies.
- Future strategies will likely involve combination therapies and novel approaches to modulate the TME.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

